Print Orders Are Now Open for Our 60th Issue!
The 10th Annual
BODY
Vol. 11, Issue No. 3
June / July 2026
One writer brushed three strands of new hair faithfully, every chance she got. Another stared at her stomach after surgery and thought, irrationally and sincerely: did they put my new belly button in the wrong spot? Another heard her body say something in a sauna, clear as sunlight, and it saved her life...
This is our 10th annual Body issue. Ten years in, our writers have never gone further inside. Twenty-two women writing from every stage, every treatment, every version of a body that has been cut, radiated, reconstructed, flattened, expanded, medicated, and somehow still here. The scars that look like closed eyelids. The nails lifting from their beds at a sister's wedding. The pill organizer that ended up on a toy boat in the toilet. The arm that will only go so far now. The ovaries that are gone and still, sometimes, throb.
This is not a magazine about surviving your body. It's about living inside it: in all the ways that's still possible, still strange, still yours.
Paper Copy Dimensions
149 full-color pages on premium paper
Book size: 4.25” x 5.5”
Limited Print Run Only! Print copies available for order only until June 29th, 2026.
Available as a dynamic digital download starting June 27th, 2026.
“My body isn’t a battleground. It’s a landscape.”
Our unique storytelling and thoughtful design put us in a category of our own.
The Body issue is for you if...
You've stood in front of a mirror after surgery and not recognized the person looking back — and stood there anyway.
You've measured your body your whole life by what it looks like, and now cancer is forcing you to reckon with what it actually does.
You've had a surgeon make a decision about your body as if it weren't yours.
You've felt the strange grief of missing body parts you didn't even know you loved until they were gone.
You've smiled through the rat race of life while your nails were lifting from their beds.
You've had your body taken over by doctors, machines, medications, and other people's opinions.
You live with metastatic disease and your body is something you negotiate with every single day.
You've had a moment when your body told you something your mind wasn't ready to hear.
You've spent years criticizing your body, and cancer is the thing that finally made you say I'm sorry.
You've gone flat, or reconstructed, or somewhere in between — and you're still figuring out what that means for who you are.
You've thought the word "resilient" about yourself and felt like it was only half the truth.
You realized you love and appreciate your post-diagnosis/treatment body way more than you ever loved your body before
Wildfire Journal is not your typical cancer magazine. Below you’ll find a sampling of real pages from within this beautiful book-ish issue.
“I wanted my old body back. What I got instead was a relationship with the new one.”
Underwriter Support Provided by:
After Breast Cancer Diagnosis (ABCD) | AnaOno | Foobs & Fitness | iRise Above Foundation | NYBRA | Pink Warrior Angels | The Busted Tank | SurvivingBreastCancer.org
Meet Guest Editor & Cover Star
Dana Donofree
Diagnosed at 27. Stage I, HER2+.
“For so many of us, a diagnosis doesn’t just interrupt life—it reshapes our relationship with our bodies in ways that are ongoing. It’s not just about treatment or recovery. It’s about identity. It’s about sensation. It’s about how we show up in the world and how we feel when we are alone in our own skin.
Sixteen years after diagnosis, I can say that my perspective on my body has evolved in ways I never could have imagined at 27.
There were years where I saw only what had been taken from me—what was scarred, what was missing, what felt unfamiliar. And then, slowly, there were moments where I began to see something else. Strength. Adaptation. Even beauty, in a way that had nothing to do with perfection.
The Body issue is not about perfection. It is not about “before and after.” It is about the now. The becoming. The ongoing process of learning to live, to feel, and to be seen in a body that tells a story.” ~ Dana, Founder of AnaOno
The “Body” Writers
The storytelling approach we take in each issue of Wildfire is deeply community-driven. Our contributors are young survivors, thrivers, and fighters, writing from inside the experience—not looking back from a comfortable distance. Each piece is curated to foster connection, validation, and a sense of belonging, ensuring that when you pick up Wildfire, you see reflections of your own fears, hopes, and transformations.
-
Lydia Amaral
Aspiring writer, travel lover, and operations director for a boutique HR firm. Diagnosed in 2024 at 39. IDC, Stage IIa, ER+, PR+, BRCA2, BRIP1, RAD51B. Current Lines of Treatment: Exemestane and Ribociclib (in a clinical trial).
-
Latanya Bispham-Robinson
LMSW, author, mother, wife, entrepreneur, go-getter. Diagnosed in 2023 at 47. IDC, Stage II, ER+. Current Line of Treatment: Tamoxifen.
-
Jessica Doig
Executive producer for multimedia experiences within museums. Diagnosed in 2024 at 49. IDC, Stage III, ER+, PR+, also has a pathogenic variant in SDHAF2 and is at increased risk for tumors related to Paraganglioma-Pheochromocytoma (PGL-PCC). Current Lines of Treatment: Letrozole, Abemaciclib, Zoladex, and Zoledronic Acid.
-
Dana Donofree
Founder of AnaOno. Diagnosed at 27. IDC, Stage I, HER2+.
-
Jennifer Gordon
Writer, massage therapist, performer, and dragon boater. Diagnosed with breast cancer in 2021 at 45. IDC, Stage II, CHEK2.
-
Anne Hilder
Former advertising creative turned writer, painter, and mother. Diagnosed in 2025 at 51. IDC, Tubular Carcinoma, Stage I, ER+, PR+. Current Lines of Treatment: Radiation, Tamoxifen.
-
Ashley Johnson
Lawyer. Diagnosed in 2021 at 38. IDC, Stage I, ER+, PR+. Diagnosed again in 2025, Stage III. Current Lines of Treatment: Zoladex, Anastrazole, Veozah.
-
Kelly Kelbel
CEO and writer. Diagnosed in 2022 at 45. Inflammatory Breast Cancer, Stage III, ER+, PR+, BRCA2. Current Lines of Treatment: Verzenio, Letrozole, Zometa.
-
Erin Kenny
Professor of anthropology. Diagnosed in 2020 at 49. IDC, Stage II, ER+. Diagnosed in 2025 at 54. IDC, Stage III, Triple Negative. Current Lines of Treatment: radiation, immunotherapy.
-
Teckla King-O'Connor
Medically retired. Diagnosed in 2016 at 37. IDC, Stage IV, ER+, PR+. In 2024, tumor expression mutated, currently ER-, PR-, HER2-low. Current Line of Treatment: Enhertu.
-
Heather Krom
Optician. Diagnosed in 2005 at 26. IDC, Stage II, Triple Positive.
-
Kia Lee
Breast cancer recovery coach and author. Diagnosed in 2023 at 38. IDC, Stage III, ER+.
-
Mary Beth Lehman
Communications strategist/CEO. Diagnosed in 2025 at 40. IDC and DCIS, Stage I, ER+, PR+.
-
Lauren M. Lemoine, PhD
Clinical psychologist, wife, and mother. Diagnosed in 2025 at 40. DCIS, Stage 0, ER+, PR+.
-
Maddy Levi
Freelance copywriter and tour guide. Diagnosed in 2009 at 48. IDC, Stage I, ER+.
-
Gillian Lichota
Marine biologist turned founder of the iRise Above Foundation. Diagnosed at 35 and 40. IDC, Stage III ER+, PR+, and then Stage IV. Current Lines of Treatment: AI, and six repurposed medications to block the metabolic pathway of dormant breast cancer cells.
-
Lindsay Lupi
Music educator and junior theater festival producer. Diagnosed in 2019 at 33. IDC, Stage II, ER+, PR+.
-
Katie Murray
Holistic literacy consultant, founder of Love of Literacy. Diagnosed at 40. ILC, Stage II, ER+. Current Line of Treatment: Tamoxifen.
-
Anj Oto
Storyteller, advocate, dog mom, wife. Diagnosed at 33. IDC, Stage I, ER+, HER2+. Current Lines of Treatment: Pleasantly on a temporary break from Lupron and Tamoxifen.
-
Kiera Powers Quezada
Diagnosed in 2025 at 30. IDC, Stage I, Triple Positive. Current Lines of Treatment: Finishing Herceptin in June 2026, Tamoxifen.
-
Katie Rabinowitz
Law school career advisor. Diagnosed at 32 and 35. DCIS, Stage 0, Triple Negative, BRCA1+, and then Stage IV. Current Lines of Treatment: Doxil and Keytruda.
-
Jennifer Wildermuth Reyes
Artist, art teacher. Diagnosed in 2025 at 46. DCIS, Stage 0, ER+
-
Mary Carmel 'Mar' Serna
Writer, trauma-informed style coach, mamma, wifey. Diagnosed in 2024 at 44. DCIS, Stage 0, ER+.
-
Kaitlyn Tomeno
Nurse anesthetist. Diagnosed in 2025 at 35, IDC/DCIS, Stage Ib, ER+, PR+, HER2-low. Current Lines of Treatment: Lupron and Letrozole.
-
Emily Voreas
Teacher. Diagnosed in 2022 at 33. IDC, Stage III, ER+, PR+, BRCA2+. Current Lines of Treatment: AI and CDK46.
Order Your Copy! Print or Digital
Paper Copies: Print copies available for order now thru June 29th, 2026.
149 full-color pages on premium paper
Book size: 4.25” x 5.5”
Digital Copies: Available as a dynamic digital download starting June 27th, 2026.
“Now my whole family goes shirtless at the drop of a hat. My daughters have never known anything different. The more I do it, the more at home I feel in my own skin. Fake it long enough, and one day you look up and realize you’re not faking anymore.”
At Wildfire, we are challenging the sterile, pink-washed narratives of traditional breast cancer media.
Each issue is a beautifully designed, book-quality collection of raw, moving, and visually rich personal essays, reflecting the reality of survivorship in all its complexity. By elevating the stories of those who have been marginalized in mainstream cancer conversations, we foster connection, advocacy, and a lasting legacy of truth-telling.
Our design philosophy is artful, immersive, and editorially rich. We blend evocative photography, bold typography, and modern layout design to create a reading experience that is both literary and visually compelling. This attention to aesthetics elevates the deeply personal narratives, reinforcing that breast cancer stories deserve the same level of artistry and care as any major literary publication.
Happy reading (and writing!).
— April Stearns, Founder & Editor-in-Chief
Get This Issue Now!
Choose Your Reading Preference
-
Subscription Option 1: Print + Digital Lush, print copies arrive on your doorstep every other month, starting with the current issue. In the meantime, you get to enjoy full access to our decade of accumulated beautiful digital archives.
Subscription Option 2: Digital-Only
True instant gratification: full access to our decade of accumulated beautiful digital archives including the current issue.✨ Either subscription option offers the most value-add and provides savings over the newsstand price.
A portion of each new subscription is donated to organizations that fund research to end the deaths from metastatic breast cancer.
-
Each issue we publish is available for individual “newsstand” purchase.
Select from instant-gratification digital downloads, or order a lush print copy to be sent to your mailbox (while copies last).
